Help for Plavix Allergy Sufferers

Tuesday, 17 Jan 2012 12:14 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Heart patients who showed allergic reactions to the life-saving blood thinner Plavix were able to remain on the drug after being treated with a combination of steroids and antihistamines as part of a study at Thomas Jefferson University Hospital. Plavix, whose chemical name is clopidogrel, helps prevent blood clots in angioplasty patients.
“This is a very important study for many cardiac patients, but especially those with stents,” said lead researcher Michael P. Savage. “Every patient who receives a stent must take Plavix to help prevent stent thrombosis, which is clotting of the stent. This obviously poses major problems if the patient suffers an allergic reaction to the medication.”
Of the 24 patients in the study, 88 percent were able to remain on Plavix. Before this treatment was discovered, patients had to endure secondary medicines that each had their own side effects.
The researchers are considering a similar approach to negative interactions from other drugs.
“Hopefully, in the future, we can expand the study and investigate ways to apply this in treating allergic reactions to other life-saving drugs,” said lead author Kimberly L. Campbell.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
You May Also Like

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved
> >